Astellas seeks Japanese regulatory approval of Evrenzo for NDD-CKD patients
Evrenzo is indicated for the treatment of anaemia associated with chronic kidney disease (CKD) in non-dialysis dependent (NDD)…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
31 Jan 20
Evrenzo is indicated for the treatment of anaemia associated with chronic kidney disease (CKD) in non-dialysis dependent (NDD)…
Exscientia CEO Andrew Hopkins has described the OCD medication reaching human trials as a "key milestone" in AI…
30 Jan 20
Selpercatinib is an oral medicine under development for the treatment of cancers with abnormalities in the rearranged during…
29 Jan 20
Dupixent is used as a treatment for atopic dermatitis in children, aged between six and 11 years, whose…
The new type 2 diabetes treatment is a daily pill containing empagliflozin, linagliptin and extended release metformin hydrochloride
28 Jan 20
The sale of brazikumab and Zenpep is expected to be closed, subject to receipt of US Federal Trade…
28 Jan 20
The new Merck Biotech Development Centre will be constructed near Merck’s current biotech commercial manufacturing site in Corsier-sur-Vevey,…
27 Jan 20
HighRes will integrate a multi-system robotics platform with advanced software control architecture for peptide and large molecule therapeutics…
24 Jan 20
TAZVERIK is indicated for the treatment of metastatic epithelioid sarcoma in patients who are not eligible for complete…
23 Jan 20
The PREDICT trial is designed to evaluate the efficacy and safety of SUBA-Itraconazole capsules, in combination with docetaxel…